Selection Criteria for Liver Transplantation
Liver transplantation candidates should be selected based on disease severity, calculated prognosis, quality of life considerations, and the absence of contraindications that would compromise post-transplant outcomes. 1, 2
Medical Evaluation Criteria
End-Stage Liver Disease
- Patients with end-stage liver disease should be referred when:
- Expected survival without transplantation is one year or less
- Major complications of cirrhosis have occurred:
- Variceal hemorrhage
- Ascites
- Hepatorenal syndrome
- Hepatic encephalopathy 1
Acute Liver Failure
- Represents an urgent indication for transplantation
- Common causes: viral hepatitis (A and B), drugs (acetaminophen), toxic agents
- Prognosis determined primarily by neurological status 1
Hepatocellular Carcinoma (HCC)
- Milan Criteria (optimal outcomes):
- Patients meeting these criteria should receive a donor organ within 6 months of listing 1
Metabolic Diseases
- Indicated for metabolic diseases causing progressive extra-hepatic injury
- Must be unresponsive to disease-specific interventions
- Transplantation should result in reversal of enzyme deficiency 1
Contraindications
Absolute Contraindications
- Metastatic cancer
- Uncontrolled sepsis
- Irreversible cerebral edema with uncal herniation
- Cholangiocarcinoma (except in research protocols)
- Alpha-fetoprotein levels >1,000 ng/ml (regardless of tumor burden) 2
- Active malignancy (except selected indolent or very low-grade cancers) 1
Relative Contraindications
- Coronary artery disease (requires thorough evaluation)
- Severe hypoxia (PaO2 ≤50 mmHg) in hepatopulmonary syndrome 1
Psychosocial Evaluation
The psychosocial evaluation is essential for identifying factors that may affect post-transplant outcomes:
- Compliance with medical regimen 1, 3
- Social support system adequacy 4, 5
- Substance abuse history and risk of relapse 1, 5
- Psychological stability and coping mechanisms 6, 7
Specific Psychosocial Criteria
- Ability to comply with complex post-transplant medical regimen
- Strong social and family support
- For alcohol-related liver disease:
Transplant Center Evaluation Process
A comprehensive evaluation at transplant centers typically includes:
- Detailed history and physical examination
- Cardiopulmonary assessment:
- Cardiac echocardiography
- Pulmonary function tests
- Dobutamine stress testing (for patients >50, smokers, or with history of heart disease/diabetes)
- Cardiac catheterization for positive stress tests
- Laboratory studies:
- Etiology and severity of liver disease
- Creatinine clearance
- Viral status (HBV, HCV, EBV, CMV, HIV)
- Abdominal imaging to determine:
- Hepatic artery and portal vein anatomy
- Presence of hepatocellular carcinoma 1
Special Considerations
Age
- No specific age limitation exists
- Older patients have diminished long-term survival primarily due to increased risk of death from malignancies 1
Previous Malignancy
- Patients with history of recently treated non-hepatic cancer require:
- Multidisciplinary assessment
- Detailed cancer- and treatment-specific information
- "Recurrence-free survival" estimates
- Evaluation of therapeutic options for potential post-LT cancer recurrence 1
Neurological Wilson's Disease
- Patients with neurological symptoms should be evaluated by transplant specialists in conjunction with neurologists
- Decision should consider possible irreversibility of neurological damage 1
The selection process must balance the ethical allocation of scarce donor organs with the goal of maximizing post-transplant survival and quality of life. Early referral to transplant centers is crucial to optimize outcomes.